CD56 EXPRESSION IN ACUTE PROMYELOCYTIC LEUKEMIA - A PREDICTIVE INDICATOR OF RELAPSE?

被引：0

作者：

Ramalheira, S. ^{[1
]}

Moreira, C. ^{[1
]}

Ferreira, C. ^{[1
]}

Leite, L. ^{[1
]}

Pereira, D. ^{[1
]}

Nunes, M. ^{[1
]}

Brito, M. ^{[1
]}

Silva, P. ^{[1
]}

Silva, R. ^{[1
]}

Martins, A. ^{[1
]}

Moreira, I. ^{[1
]}

Oliveira, I. ^{[1
]}

Viterbo, L. ^{[1
]}

Domingues, N. ^{[1
]}

Chacim, S. ^{[1
]}

Sousa, E. ^{[2
]}

Godinho, I. ^{[2
]}

Martins, G. ^{[2
]}

Mendes, C. ^{[3
]}

Santo, A. ^{[1
]}

Mariz, J. ^{[1
]}

机构：

[1] Inst Portugues Oncol Porto, EPE, Oncohematol, Porto, Portugal

[2] Inst Portugues Oncol Porto, EPE, Unidade Citometria Fluxo, Serv Hematol Lab, Porto, Portugal

[3] Inst Portugues Oncol Porto, EPE, Serv Hematol Lab, Porto, Portugal

来源：

HAEMATOLOGICA | 2013年 / 98卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

B1263

引用

页码：519 / 519

页数：1

共 50 条

[21] Prognostic significance of CD56 antigen expression in patients with acute myeloid leukemia
Irena Djunic
Marijana Virijevic
Vladislava Djurasinovic
Aleksandra Novkovic
Natasa Colovic
Nada Kraguljac-Kurtovic
Ana Vidovic
Nada Suvajdzic-Vukovic
Dragica Tomin
Medical Oncology, 2012, 29 : 2077 - 2082
[22] Acute myeloid leukemia (AML) with CD56 expression - A very high incidence of CD56 expression in AML with t(8;21) in Taiwan.
Hsiao, CH
Tang, JL
Yao, M
Tsay, W
Wang, CH
Chen, YC
Shen, MC
Tien, HF
BLOOD, 2000, 96 (11) : 190B - 191B
[23] CD56 expression is an indicator of poor clinical outcome in patients with acute promyelocytic leukemia (APL) treated with simultaneous all-trans retinoic acid (ATRA) and chemotherapy.
Ferrara, F
Morabito, F
Martino, B
Specchia, G
Liso, V
Boccuni, P
Di Noto, R
Pane, F
Annunziata, M
Schiavone, EM
Guglielmi, C
Del Vecchio, L
Lo Coco, F
BLOOD, 1999, 94 (10) : 696A - 696A
[24] Prognostic impact of CD200 and CD56 expression in adult acute lymphoblastic leukemia patients
Aref, Salah
Azmy, Emad
El-Bakry, Kadry
Ibrahim, Lobna
Mabed, Mohamed
HEMATOLOGY, 2018, 23 (05) : 263 - 270
[25] The diagnostic power of CD117, CD13, CD56, CD64, and MPO in rapid screening acute promyelocytic leukemia
Vinh Thanh Tran
Thang Thanh Phan
Hong-Phuoc Mac
Tung Thanh Tran
Toan Trong Ho
Suong Phuoc Pho
Van-Anh Ngoc Nguyen
Truc-My Vo
Hue Thi Nguyen
Thao Thi Le
Tin Huu Vo
Son Truong Nguyen
BMC Research Notes, 13
[26] The diagnostic power of CD117, CD13, CD56, CD64, and MPO in rapid screening acute promyelocytic leukemia
Vinh Thanh Tran
Thang Thanh Phan
Hong-Phuoc Mac
Tung Thanh Tran
Toan Trong Ho
Suong Phuoc Pho
Van-Anh Ngoc Nguyen
Truc-My Vo
Hue Thi Nguyen
Thao Thi Le
Tin Huu Vo
Son Truong Nguyen
BMC RESEARCH NOTES, 2020, 13 (01)
[27] CD56 antigenic expression in acute myeloid leukemia identifies patients with poor clinical prognosis
Raspadori, D
Damiani, D
Lenoci, M
Rondelli, F
Testoni, N
Nardi, G
Sestigiani, C
Mariotti, C
Birtolo, S
Tozzi, M
Lauria, F
LEUKEMIA, 2001, 15 (08) : 1161 - 1164
[28] CD56 expression in acute myeloid leukemia identifies patients with poor clinical outcome.
Raspadori, D
Bellisai, B
Birtolo, S
Forconi, F
Lenoci, M
Nardi, G
Scalia, G
Sestigiani, C
Vessichelli, F
Lauria, F
BLOOD, 1998, 92 (10) : 606A - 606A
[29] CD56 expression in acute myeloid leukemia (AML) with monocytic differentiation: Association with complex karyotype
Uherova, P
Roulston, D
Finn, WG
Valdez, R
Schnitzer, B
Ross, CW
LABORATORY INVESTIGATION, 2002, 82 (01) : 267A - 268A
[30] CD56 expression in acute myeloid leukemia (AML) with monocytic differentiation: Association with complex karyotype
Uherova, P
Roulston, D
Finn, WG
Valdez, R
Schnitzer, B
Ross, CW
MODERN PATHOLOGY, 2002, 15 (01) : 267A - 268A

← 1 2 3 4 5 →